Research Topics
| Ken J HarveySummaryAffiliation: La Trobe University Country: Australia Publications
| Collaborators |
Detail Information
Publications
eTG completeKen J Harvey
Med J Aust 178:142-3. 2003
Pharmaceutical advertisements in prescribing software: an analysisKen J Harvey
School of Public Health, La Trobe University, Plenty Road, Bundoora, VIC 3086
Med J Aust 183:75-9. 2005..To assess pharmaceutical advertisements in prescribing software, their adherence to code standards, and the opinions of general practitioners regarding the advertisements...
Improving antibiotic use: 25 years of antibiotic guidelines and related initiativesKen Harvey
Therapeutic Guidelines Limited, School of Public Health, La Trobe University, Bundoora, Victoria
Commun Dis Intell 27:S9-12. 2003..In addition, the increasing use of computerised prescribing programs has highlighted the need for electronic guidelines to be closely integrated with decision support software...
Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?Ken J Harvey
School of Public Health, La Trobe University, Plenty Road, Bundoora, VIC 3086, Australia
Med J Aust 181:256-9. 2004..We support the many concerned health and consumer organisations who have asked the Senate either not to pass the enabling legislation, or to delay its passage until a fairer deal in terms of public health can be obtained...
Croatian pharmaceutical sector reform project: rational drug useKen Harvey
School of Public Health, La Trobe University, Bundoora, Australia
Croat Med J 45:611-9. 2004..We understand that the Croatian government has accepted a number of these recommendations and, in particular, performance indicators (and financial incentives) are written into new contracts for Croatian general practitioners in 2004...
Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits SchemeKen Harvey
School of Public Health, La Trobe University, Bundoora, VIC 3086, Australia
Aust Health Rev 28:218-26. 2004....
Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?Ken J Harvey
School of Public Health, La Trobe University, Melbourne, Vic, Australia
Med J Aust 194:567-8. 2011..The cost differential between these two drugs is no longer defensible...
A review of proposals to reform the regulation of complementary medicinesKen J Harvey
School of Public Health, La Trobe University, VIC 3086
Aust Health Rev 33:279-87. 2009..Complaint procedures are overloaded and the "sanctions" available do not deter repeat offenders. A number of regulatory reforms have been suggested to overcome these problems; they are reviewed in this paper...
Commercialism, choice and consumer protection: regulation of complementary medicines in AustraliaKen J Harvey
School of Public Health, La Trobe University, Melbourne, Vic, Australia
Med J Aust 188:21-5. 2008..Complaint procedures (now overloaded) are no substitute for adequate regulation at the time of market entry. Regulatory reform of listed and homoeopathic products is required...
The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?Ken J Harvey
Med J Aust 187:206-7. 2007
